tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Paul Choi, 32 are a SELL (14.68%), 77 are a HOLD (35.32%), 109 are a BUY (50%).
Analyst Paul Choi, carries an average stock price target met ratio of 59.79% that have a potential upside of 32.5% achieved within 184 days. Previously, Paul Choi worked at GOLDMAN SACHS, BARCLAYS.
Paul Choi’s has documented 425 price targets and ratings displayed on 52 stocks. The coverage was on Healthcare, Pharmaceuticals, Technology sectors.
Most recent stock forecast was given on KNSA, Kiniksa Pharmaceuticals Ltd at 29-Jul-2026.
Analyst best performing recommendations are on SBTX (SILVERBACK THERAPEUTICS).
The best stock recommendation documented was for VIR (VIR BIOTECHNOLOGY) at 3/1/2021. The price target of $61 was fulfilled within 1 day with a profit of $5.73 (8.59%) receiving and performance score of 85.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$3
$1.79 (147.93%)
$3
2 years 5 days ago
(26-Sep-2024)
0/4 (0%)
$2.42 (417.24%)
Hold
$7
2 years 3 months 11 days ago
(20-Jun-2024)
1/3 (33.33%)
$0.45 (6.87%)
57
Sell
$1
$-0.21 (-17.36%)
$1.5
2 years 8 months 14 days ago
(17-Jan-2024)
6/6 (100%)
$-0.02 (-1.96%)
278
Buy
2 years 9 months 13 days ago
(18-Dec-2023)
1/1 (100%)
$32.69 (83.16%)
358
Buy
$9
$7.79 (643.80%)
3 years 4 months 20 days ago
(11-May-2023)
2/4 (50%)
$4.84 (116.35%)
178
Which stock is Paul Choi most bullish on?
